Saunora Prom, DO
Sports Medicine · Chesapeake, VANPI 1619179363
Payments from drug & device makers
Across 163 payments — averaging $23.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bioventus LLC$970
- Novo Nordisk$281
- Fidia Pharma USA Inc.$256
- Johnson & Johnson$218
- Pacira Pharmaceuticals Incorporated$190
- Ferring Pharmaceuticals Inc.$186
- plus $2K from 30 others
What the payments were for
- Food & beverage$3,877100%
- Education$170%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bioventus LLC | 17 | $970 |
| Novo Nordisk | 17 | $281 |
| Fidia Pharma USA Inc. | 14 | $256 |
| Johnson & Johnson(2 entities) | 12 | $218 |
| Pacira Pharmaceuticals Incorporated | 3 | $190 |
| Ferring Pharmaceuticals Inc. | 11 | $186 |
| AbbVie | 7 | $135 |
| GSK | 8 | $134 |
| AstraZeneca | 9 | $132 |
| Medtronic | 2 | $129 |
| Pacira Therapeutics, Inc. | 8 | $126 |
| Boehringer Ingelheim | 8 | $125 |
| Averitas Pharma Inc. | 1 | $119 |
| Electronic Waveform Lab, Inc. | 7 | $112 |
| Abbott | 5 | $106 |
| Boston Scientific | 1 | $99 |
| Lilly USA, LLC | 6 | $82 |
| Trice Medical, Inc. | 2 | $63 |
| Dexcom, Inc. | 3 | $54 |
| Amgen | 2 | $47 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Sanofi Pasteur Inc. | 1 | $26 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Merck | 2 | $25 |
| Endo USA, Inc. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Insulet Corporation | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Pfizer | 1 | $17 |
| Genentech USA, Inc. | 1 | $15 |
| Ultragenyx Pharmaceutical Inc. | 1 | $15 |
| Corcept Therapeutics | 1 | $15 |
| Fortis Surgical, LLC | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $13 |
| Amarin Pharma, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,893 in reported general payments places this provider in the 55th percentile of 171 sports medicine providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 60 | $894 |
| Gabapentin | 29 | $292 |
| Naproxen | 13 | $74 |
| Prednisone | 14 | $11 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Chesapeake
- Bryson KemlerChesapeake$46K
- David DiduchCharlottesville$4M
- Thorp DavisMechanicsville$3M
- Stephen BrockmeierCharlottesville$2.6M
- William NordtRichmond$2.6M
- Justin GriffinVirginia Beach$2.1M
- Kevin BonnerVirginia Beach$1.7M
- Brian WernerCharlottesville$1.6M
- Kenneth ZaslavRichmond$1M
- Asheesh GuptaWoodbridge$467K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.